The groundbreaking approach of this peptide represents a major development in the handling of type 2 diabetes. Different to existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide752849.tribunablog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-56802385